A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery

Coronary Artery Disease

Volumn 17, Issue 2, 2006, Pages 173-179

  Schouten, Olaf ^a   Shaw, Leslee J ^c   Boersma, Eric ^a   Bax, Jeroen J ^b   Kertai, Miklos D ^a   Feringa, Harm H H ^a   Biagini, Elena ^a   Kok, Niels F M ^a   Urk, Hero Van ^a   Elhendy, Abdou ^d   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

blocker; Cardiac complications; Meta analysis; Perioperative

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRONCHOSPASM; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; LUNG EDEMA; MEDICAL LITERATURE; META ANALYSIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADRENERGIC BETA-ANTAGONISTS; DEATH, SUDDEN, CARDIAC; HUMANS; MYOCARDIAL ISCHEMIA; PERIOPERATIVE CARE; SURGICAL PROCEDURES, OPERATIVE;

EID: 33748563130     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200603000-00012     Document Type: Article

References (39)

1. Hall MJ, Owings MF. 2000 National Hospital Discharge Survey. Adv Data 2002; (329):1-18.
2. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72:153-184.
3. Auerbach AD, Goldman L. Beta-Blockers and reduction of cardiac events in noncardiac surgery: clinical applications. JAMA 2002; 287:1445-1447.
4. McFalls EO, Ward HB, Santilli S, Scheftel M, Chesler E, Doliszny KM. The influence of perioperative myocardial infarction on long-term prognosis following elective vascular surgery. Chest 1998; 113:681-686.
5. Jamieson WR, Janusz MT, Miyagishima RT, Gerein AN. Influence of ischemic heart disease on early and late mortality after surgery for peripheral occlusive vascular disease. Circulation 1982; 66(Pt 2):I92-I97.
6. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049.
7. Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1997; 297:845-850.
8. Gordon AJ, Macpherson DS. Guideline chaos: conflicting recommendations for preoperative cardiac assessment. Am J Cardiol 2003; 91:1299-1303.
9. Grayburn PA, Hillis LD. Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 2003; 138:506-511.
10. Kertai MD, Steyerberg EW, Boersma E, Bax JJ, Vergouwe Y, Van Urk H, et al. Validation of two risk models for perioperative mortality in patients undergoing elective abdominal aortic aneurysm surgery. Vasc Endovascular Surg 2003; 37:13-21.
11. Larsen SF, Olesen KH, Jacobsen E, Nielsen H, Nielsen AL, Pietersen A, et al. Prediction of cardiac risk in non-cardiac surgery. Eur Heart J 1987; 8:179-185.
12. Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 1995; 333:1750-1756.
13. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804.
14. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Anesth Analg 2002; 94:1052-1064.
15. Bayliff CD, Massel DR, Inculet RI, Malthaner RA, Quinton SD, Powell FS, Kennedy RS. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 1999; 67:182-186.
16. Bohm M, Maack C, Wehrlen-Grandjean M, Erdmann E. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)). Z Kardiol 2003; 92:668-676.
17. Coleman AJ, Jordan C. Cardiovascular responses to anaesthesia. Influence of beta-adrenoreceptor blockade with metoprolol. Anaesthesia 1980; 35:972-978.
18. Cucchiara RF, Benefiel DJ, Matteo RS, DeWood M, Albin MS. Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology 1986; 65:528-531.
19. Davies MJ, Dysart RH, Silbert BS, Scott DA, Cook RJ. Prevention of tachycardia with atenolol pretreatment for carotid endarterectomy under cervical plexus blockade. Anaesth Intensive Care 1992; 20:161-164.
20. Jakobsen CJ, Bille S, Ahlburg P, Rybro L, Pedersen KD, Rasmussen B. Preoperative metoprolol improves cardiovascular stability and reduces oxygen consumption after thoracotomy. Acta Anaesthesiol Scand 1997; 41:1324-1330.
21. Magnusson H, Ponten J, Sonander HG. Methohexitone anaesthesia for microlaryngoscopy: circulatory modulation with metoprolol and dihydralazine. Br J Anaesth 1986; 58:976-982.
22. Magnusson J, Thulin T, Werner O, Jarhult J, Thomson D. Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. Br J Anaesth 1986; 58:251-260.
23. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341:1789-1794.
24. Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C, Whittemore AD. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999; 88:477-482.
25. Rosenberg J, Overgaard H, Andersen M, Rasmussen V, Schulze S. Double blind randomised controlled trial of effect of metoprolol on myocardial ischaemia during endoscopic cholangiopancreatography. BMJ 1996; 313:258-261.
26. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988; 68:495-500.
27. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000; 90:1257-1261.
28. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88:7-17.
29. Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Krol M, Bodian C, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999; 91:1674-1686.
30. Cruickshank JM. Beta-blockers continue to surprise us. Eur Heart J 2000; 21:354-364.
31. Warltier DC, Pagel PS, Kersten JR. Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology 2000; 92:253-239.
32. Saxena PR. Beta-adrenoceptor antagonists and blood flow to the jeopardized myocardium. Eur Heart J 1983; 4:101-108.
33. Wallhaus TR, Taylor M, DeGrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation 2001; 103:2441-2446.
34. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003; 97:623-633.
35. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 2002; 287:1435-1444.
36. Devereaux PJ, Beattie SW, Choi PTL, Badner NH, Guyatt GH, Villar JC, et al. How strong is the evidence for the use of perioperative beta blockers in noncardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005; 331:313-321.
37. Kertai MD, Boersma E, Bax JJ, Thomson IR, Cramer MJ, van de Ven LL, et al. Optimizing long-term cardiac management after major vascular surgery: role of beta-blocker therapy, clinical characteristics, and dobutamine stress echocardiography to optimize long-term cardiac management after major vascular surgery. Arch Intern Med 2003; 163:2230-2235.
38. Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 1991; 151:1769-1776.
39. Ubbink DT, Verhaar EE, Lie HK, Legemate DA. Effect of beta-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease. J Vasc Surg 2003; 38:535-540.